Being engaged in clinical trials and clinical pharmacology for more than 15 years. Proficient and experienced in clinical research management. Participated in more than 100 phase I (including pharmacokinetics, tolerance, drug-drug interactions, food-drug interactions, metabolism, and bioequivalence) trials, among which more than 20 projects are undertaken as PI. Presided over 1 National Natural Science Foundation, 1 sub subject of a 13th Five-Year Plan on Major New Drug Creation and 2 provincial projects, also participated in more than 20 scientific research projects. Among 50 publications, 13 of them are published as first-author or correspondence author. 

Phase I clinical trial

Clinical pharmacology

Chemoresistance

Advanced Study in the Department of Clinical Pharmacology in Vienna General Hospital of Austria.

Invited for poster presentation of phase I clinical trial results at 2016/2017 ACCP Annual Conference

Expert group member of on-site inspection and review panel of CFDI of NMPA

Member of the Committee of Drug Clinical Trial Special Committee of Chinese Pharmacology Society

Member of the Youth Committee of Tumor Big Data and Real World Research of Chinese Anti-cancer Association

Member of the PKPD Group of Drug Evaluation Research Committee of Chinese Pharmaceutical Society

Member of Committee of Drug Clinical Trials of Zhejiang Pharmaceutical Society